Refreshing results…
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma
UploadT-cell Lymphoma and Secondary Primary Malignancy Risk After Commercial CAR T-cell Therapy
UploadNo CNS sanctuary for lymphoma from CAR T
Download from ashpublications.orgGut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
UploadPembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy
Download from ashpublications.orgCAR T cell viability release testing and clinical outcomes: is there a lower limit?
UploadMissing publications? Search for publications with a matching author name.